Liraglutide improves hepatic insulin resistance via the canonical Wnt signaling pathway.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Medicine Reports

• Publication date

  2018-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3892/mmr.2018.8737PMID 29568881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases

  2017cited by this paper
• Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress

  2016cited by this paper
• Elevated Hepatic miR-22-3p Expression Impairs Gluconeogenesis by Silencing the Wnt-Responsive Transcription Factor Tcf7

  2015cited by this paper
• Cardiometabolic Effects of a New Class of Antidiabetic Agents.

  2015cited by this paper
• Liver-Specific Expression of Dominant-Negative Transcription Factor 7-Like 2 Causes Progressive Impairment in Glucose Homeostasis

  2015cited by this paper
• Translocation of forkhead box O1 to the nuclear periphery induces histone modifications that regulate transcriptional repression of PCK1 in HepG2 cells

  2015cited by this paper
• Glucagon-like peptide-1: glucose homeostasis and beyond.

  2014cited by this paper
• Forkhead box class O transcription factors in liver function and disease

  2013cited by this paper
• Omeprazole improves the anti‐obesity and antidiabetic effects of exendin‐4 in db/db mice (奥美拉唑改善唾液素‐4 对db/db小鼠的减肥与降糖作用) *

  2013cited by this paper
• Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

  2013cited by this paper
• The Wnt Signaling Pathway Effector TCF7L2 Controls Gut and Brain Proglucagon Gene Expression and Glucose Homeostasis

  2013cited by this paper
• Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice

  2012cited by this paper
• Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice

  2012cited by this paper
• The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis.

  2012influential reference
• The role of the Wnt signaling pathway in incretin hormone production and function

  2012cited by this paper
• Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand.

  2012cited by this paper
• New insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells

  2012cited by this paper
• Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice

  2011influential reference
• Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal Non-Diabetic Mice, Possible Contribution of Beta Cell Independent Effects

  2011influential reference
• Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism

  2011influential reference
• Wnt Signaling Regulates Hepatic Metabolism

  2011cited by this paper
• Insulin alters the expression of components of the Wnt signaling pathway including TCF-4 in the intestinal cells.

  2010influential reference
• Glucagon‐like peptide‐1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

  2010cited by this paper
• Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes

  2010cited by this paper
• WNT signalling is both an inducer and effector of glucagon-like peptide-1

  2008cited by this paper
• Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice

  2008cited by this paper
• Glucagon-like Peptide-1 Activation of TCF7L2-dependent Wnt Signaling Enhances Pancreatic Beta Cell Proliferation*

  2008influential reference
• Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells.

  2008influential reference
• Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity*

  2008cited by this paper
• The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.

  2008cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• WNT/beta-catenin signaling in liver health and disease.

  2007cited by this paper
• Exendin‐4, a glucagon‐like protein‐1 (GLP‐1) receptor agonist, reverses hepatic steatosis in ob/ob mice

  2006cited by this paper
• Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

  2006cited by this paper
• Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination.

  2005cited by this paper
• Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

  2004cited by this paper
• Cell signalling of the GLP-1 action in rat liver.

  2003cited by this paper
• Effects of berberine on glucose metabolism in vitro.

  2002cited by this paper
• Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Wnt/beta-catenin signaling.

  2000cited by this paper
• Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.

  1997cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper

• White kidney bean extract improves letrozole-induced polycystic ovary syndrome in rats by regulating the Wnt signaling pathway.

  2025cites this paper
• Role of Liraglutide in weight management and reproductive health in women with obesity and PCOS- A critical review of the evidence

  2025cites this paper
• Lipid droplet dynamics in type 2 diabetes and its complications: pathophysiological insights and therapeutic options

  2025cites this paper
• Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis

  2025cites this paper
• TP508 Promotes Bone Regeneration on Distraction Osteogenesis via the Activation of Wnt/β-catenin Signaling Pathway.

  2024cites this paper
• Regulated and adaptive in vivo insulin secretion from islets only containing β-cells

  2024cites this paper
• Insights on effects of Wnt pathway modulation on insulin signaling and glucose homeostasis for the treatment of type 2 diabetes mellitus: Wnt activation or Wnt inhibition?

  2024cites this paper
• GLP‑1 receptor agonist protects palmitate-induced insulin resistance in skeletal muscle cells by up-regulating sestrin2 to promote autophagy

  2023cites this paper
• Liraglutide Attenuates Hepatic Oxidative Stress, Inflammation, and Apoptosis in Streptozotocin-Induced Diabetic Mice by Modulating the Wnt/β-Catenin Signaling Pathway

  2023influential citation
• Effects of liraglutide on ANP secretion and cardiac dynamics

  2023cites this paper
• Mechanism of GLP-1 Receptor Agonists-Mediated Attenuation of Palmitic Acid-Induced Lipotoxicity in L6 Myoblasts

  2022cites this paper
• Shared signaling pathways and targeted therapy by natural bioactive compounds for obesity and type 2 diabetes

  2022cites this paper
• Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer’s Disease and Type 2 Diabetes

  2021cites this paper
• Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist

  2020cites this paper
• Revealing the Interactions Between Diabetes, Diabetes-Related Diseases, and Cancers Based on the Network Connectivity of Their Related Genes

  2020cites this paper
• Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway

  2019influential citation
• Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2019influential citation